Association between in-line filtration and Type I hypersensitivity reactions in pediatric oncology patients receiving intravenous etoposide-Reference-Cited by-同舟云学术

Association between in-line filtration and Type I hypersensitivity reactions in pediatric oncology patients receiving intravenous etoposide

Published:2020-11-05 Issue:3 Volume:38 Page:208-215
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Ronsley Rebecca¹,Jacques Lisa¹,Potts James E.¹,Clement Kerri¹,Dix David B.¹,Mahon Paula¹²^ORCID

Affiliation:

1. Division of Hematology, Oncology and Bone Marrow Transplant, British Columbia Children’s Hospital, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada

2. School of Nursing, The University of British Columbia, Vancouver, British Columbia, Canada

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2020.1838011

Reference23 articles.

1. Clinical applications of anticancer drugs targeted to topoisomerase II

2. Etoposide for the treatment of paediatric tumours: What is the best way to give it?

3. Etoposide medication monograph. BC Cancer Agency Cancer; 2017. http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Etoposide_monograph.pdf.

4. Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide

5. Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Approach to Deciphering Etoposide Infusion Reactions and Potential Role of Polyethersulfone Filter Membranes;The Journal of Pediatric Pharmacology and Therapeutics;2023-11-01

2. Etoposide hypersensitivity reactions associated with in-line filter use: A retrospective cohort study at CHU de Québec-Université Laval;Journal of Oncology Pharmacy Practice;2022-12-21

3. Risks and mitigation strategies to prevent etoposide infusion‐related reactions in children;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-06-29